Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

Abstract There is considerable potential for integrating transarterial chemoembolization (TACE), programmed death-(ligand)1 (PD-[L]1) inhibitors, and molecular targeted treatments (MTT) in hepatocellular carcinoma (HCC). It is necessary to investigate the therapeutic efficacy and safety of TACE comb...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Hai‐Dong Zhu, Hai-Liang Li, Mingsheng Huang, Yang Weizhu, Guowen Yin, Bin‐Yan Zhong, Jun‐Hui Sun, Zhi‐Cheng Jin, Jian-Jia Chen, Naijian Ge, Wen‐Bin Ding, Wenhui Li, Jinhua Huang, Wei Mu, Shanzhi Gu, Jiaping Li, Hui Zhao, Wen Shu-wei, Yanming Lei, Yusheng Song, Chunwang Yuan, Weidong Wang, Ming Huang, Wei Zhao, Jianbing Wu, Song Wang, Xu Zhu, Jianjun Han, Weixin Ren, Zaiming Lu, Wenge Xing, Yong Fan, Hailan Lin, Zishu Zhang, Guohui Xu, Wenhao Hu, Qiang Tu, Hongying Su, Chuansheng Zheng, Yong Chen, Xuya Zhao, Zhu-ting Fang, Qi Wang, Jinwei Zhao, Aibing Xu, Jian Xu, Qinghua Wu, Huanzhang Niu, Jian Wang, Feng Dai, Duiping Feng, Qingdong Li, Rong-Shu Shi, Jiarui Li, Guang Yang, Hai‐Bin Shi, Jiansong Ji, Yue Liu, Zheng Cai, Po Song Yang, Yang Zhao, Xiaoli Zhu, Ligong Lu, Gao‐Jun Teng
Format: Artigo
Jezik:angleščina
Izdano: 2023
Online dostop:https://doi.org/10.1038/s41392-022-01235-0
https://www.nature.com/articles/s41392-022-01235-0.pdf
Oznake: Označite
Brez oznak, prvi označite!